Clinical trials & evidence

Can cortisol become the next target in type 2 diabetes?

An ADC Steps Into the First-Line Gap in Triple-Negative Breast Cancer

Alpha Radioligand Therapy Moves Prostate Cancer Into a New Infrastructure Test

AI Pathology Starts Moving Toward Treatment Selection

Hepatitis B Functional Cure Moves Closer, But Access Still Starts With Diagnosis

Huntington’s Disease Gets an Oral Target-Engagement Signal

AI Multiomics Moves Into the Trial Stratification Layer

A New CELMoD Raises the Bar in Relapsed Myeloma
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
